The firm has begun enrolling patients in the Phase I portion of the trial More: Novavax launches trial of coronavirus vaccine candidate Source: News
read moreThe move is based on data showing Alunbrig’s superiority over crizotinib as first-line treatment of metastatic ALK+ NSCLC More: New US approval for Takeda’s Alunbrig Source: News
read moreThe move does not affect the firms’ ongoing collaboration More: Sanofi to sell stake in Regeneron Source: News
read moreArcherDX will perform whole exome sequencing of NSCLC patient samples to generate personalised ctDNA assays to test for MRD More: AZ links with ArcherDX to detect minimal residual disease in lung cancer patients Source: News
read moreThe Solidarity trial’s expert group will review all evidence available on the drug More: WHO pauses hydroxycholoroquine arm in COVID-19 trial Source: News
read moreGlaxoSmithKline hands Samsung Biologics $231M to scale up manufacturing aliu Fri, 05/22/2020 – 11:34 More: GlaxoSmithKline hands Samsung Biologics 1M to scale up manufacturing Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals